Trial Profile
The efficacy of Gabapentin in the management of post menopausal sleep disorder and life quality
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Menopausal syndrome; Sleep disorders
- Focus Therapeutic Use
- 27 Jun 2013 Recruitment is expected to complete on the 1st of September 2013.
- 27 Jun 2013 New trial record